Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd StudyCLINICAL CANCER RESEARCHIF10.22021-01-0454OAAI